Curi RMB Capital LLC Sells 3,652 Shares of CME Group Inc. (NASDAQ:CME)

Curi RMB Capital LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 128,480 shares of the financial services provider's stock after selling 3,652 shares during the period. Curi RMB Capital LLC's holdings in CME Group were worth $28,349,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Y.D. More Investments Ltd bought a new position in shares of CME Group during the 2nd quarter worth about $36,000. McClarren Financial Advisors Inc. boosted its holdings in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider's stock valued at $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC grew its stake in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider's stock valued at $40,000 after purchasing an additional 170 shares during the period. Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider's stock worth $43,000 after buying an additional 74 shares in the last quarter. Finally, Bank & Trust Co acquired a new position in shares of CME Group in the 2nd quarter worth approximately $76,000. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business's stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company's stock, valued at $11,932,706.13. The trade was a 12.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm's stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company's stock, valued at $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a report on Thursday, October 24th. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the stock an "equal weight" rating in a report on Thursday, October 24th. TD Cowen initiated coverage on CME Group in a report on Thursday, September 26th. They set a "hold" rating and a $221.00 price target for the company. The Goldman Sachs Group boosted their price objective on CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a research note on Thursday, October 3rd. Finally, Piper Sandler raised their target price on CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a research note on Monday, October 28th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $224.47.

CME Group Stock Down 2.1 %

Shares of CME traded down $4.72 on Thursday, hitting $223.42. The company's stock had a trading volume of 1,816,551 shares, compared to its average volume of 1,913,519. The firm's fifty day moving average price is $222.44 and its 200-day moving average price is $210.17. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of $80.45 billion, a price-to-earnings ratio of 23.99, a P/E/G ratio of 5.69 and a beta of 0.55.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business earned $2.25 EPS. The company's revenue for the quarter was up 18.4% compared to the same quarter last year. On average, equities research analysts expect that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.06%. The ex-dividend date of this dividend is Monday, December 9th. CME Group's payout ratio is 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.